| Sep 9 2024 |
Alabama Court Signals Possible Willingness to Allow Medical Program to Move Forward in Part |
Bradley Arant Boult Cummings LLP |
| Sep 9 2024 |
China Expands Pilot Program for Foreign Investment in the Healthcare Sector |
Sheppard, Mullin, Richter & Hampton LLP |
| Sep 6 2024 |
Dos and Don’ts for Advertising, Packaging and Labeling of Cannabis Products in Illinois |
Sheppard, Mullin, Richter & Hampton LLP |
| Sep 6 2024 |
DEA Will Hold Public Hearing to Address Marijuana Rescheduling |
Jackson Lewis P.C. |
| Sep 6 2024 |
Seasonal Considerations for Packaging and Selling Alcoholic Beverages |
McDermott Will & Emery |
| Sep 6 2024 |
DOD Announces Seven Awards via the Distributed Bioindustrial Manufacturing Program |
Bergeson & Campbell, P.C. |
| Sep 6 2024 |
McDermott+ Check-Up: September 6, 2024 |
McDermott Will & Emery |
| Sep 6 2024 |
Obtaining Clearances Through FDA's Food Contact Notification Program |
K&L Gates LLP |
| Sep 6 2024 |
Federal Court Permits Investors to Resume Kickback Suit Against Teva |
ArentFox Schiff LLP |
| Sep 6 2024 |
FDA Publishes FY2022 Pesticide Residue Monitoring Program Report |
Keller and Heckman LLP |
| Sep 6 2024 |
HHS-OIG Declines Sanctions on Diabetes Patient Program Subsidizing Medicare Cost-Sharing |
Barnes & Thornburg LLP |
| Sep 6 2024 |
House Subcommittee Will Hold Legislative Hearing on Evaluating FDA Human Foods and Tobacco Programs |
Bergeson & Campbell, P.C. |
| Sep 6 2024 |
Plaintiff’s Attorney Spencer Sheehan Sanctioned |
Keller and Heckman LLP |
| Sep 6 2024 |
Looking For a Drink At 3 A.M.? Soon, You May Find One Here |
Allen Matkins Leck Gamble Mallory & Natsis LLP |
| Sep 5 2024 |
Class Action Litigation Newsletter | 2nd Quarter 2024 |
Greenberg Traurig, LLP |
| Sep 5 2024 |
George Washington’s Whisky Distillery, 21st Century Edition |
Bradley Arant Boult Cummings LLP |
| Sep 5 2024 |
USPTO Issues Updated AI Subject Matter Eligibility Guidance |
ArentFox Schiff LLP |
| Sep 5 2024 |
China Calls for Submissions of New Health Claims |
Keller and Heckman LLP |
| Sep 5 2024 |
BETO Calls for Feedstock-Conversion Interface Consortium Industry Partnerships |
Bergeson & Campbell, P.C. |
| Sep 4 2024 |
Attorney’s Fees May Be Recoverable in Trade Secret Cases, Even Without Damages |
Sheppard, Mullin, Richter & Hampton LLP |
| Sep 4 2024 |
FDA Continues to Intentionally Incorporate AI into Medical Product Development with Its Establishment of a New Internal Advisory Body |
Mintz |
| Sep 4 2024 |
This Week in 340B: August 27 – September 2, 2024 |
McDermott Will & Emery |
| Sep 3 2024 |
DEA Announces December Hearing on Proposal to Reschedule Marijuana |
ArentFox Schiff LLP |
| Sep 3 2024 |
DOL: Indefinite Delay in FLAG System Update for New H-2A Farmworker Visa Rule |
Jackson Lewis P.C. |
| Sep 3 2024 |
California School Food Dye Ban Approved by Legislature |
Keller and Heckman LLP |
| Sep 3 2024 |
The 340B ‘Saga’ Continues: As More States Pass 340B Contract Pharmacy Laws, More Lawsuits Follow |
ArentFox Schiff LLP |
| Sep 3 2024 |
Update: OHCA Approves Amendments to Cost and Market Impact Review (CMIR) Regulations |
Sheppard, Mullin, Richter & Hampton LLP |
| Sep 3 2024 |
Brussels Regulatory Brief: Summer 2024 |
K&L Gates LLP |
| Sep 3 2024 |
Unpacking Averages: How Old Are Medical Devices on the US Market? |
Epstein Becker & Green, P.C. |
| Aug 30 2024 |
Maine Updates Ownership Disclosure Requirements |
McDermott Will & Emery |
| Aug 30 2024 |
Major Changes Coming for Medicare Drug Program: Negotiated Prices, Cap on Out of Pocket and Creditable Coverage |
Norris McLaughlin P.A. |
| Aug 30 2024 |
USDA Releases Updated Guideline Regarding Animal-Raising and Environment-Related Claims on Meat and Poultry |
Keller and Heckman LLP |
| Aug 30 2024 |
EPA Finalizes Novel Herbicide Strategy to Protect Endangered Species |
Beveridge & Diamond PC |
| Aug 29 2024 |
Key Elements of an AI Governance Program in Healthcare |
Sheppard, Mullin, Richter & Hampton LLP |
| Aug 29 2024 |
2024 CPSC and FDA Enforcement Trends |
Foley & Lardner LLP |
